After uncovering Ogden syndrome in 2011, reports of different nonlethal NAA10 variants in males as well as mostly de novo variants in affected female index cases with nonspecific ID have been published, expanding the clinical spectrum and elucidating the underlying complexity of NAA10 deficiency (see Figure 4). This evidence concerns the gene NAA10 and Ogden syndrome.